State of Wisconsin Investment Board’s Harvard Bioscience HBIO Stock Holding History

State of Wisconsin Investment Board’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,020	Closed	-$57.6K	–	2315
2024 Q2	$57.6K	Buy	2,020 +90	+5%	+$3.16K	﹤0.01%	2244
2024 Q1	$81.8K	Buy	+1,930	New	+$86.8K	﹤0.01%	2146
2022 Q4	–	Sell	-1,030	Closed	-$26K	–	2569
2022 Q3	$26K	Sell	1,030 -3,000	-74%	-$99.2K	﹤0.01%	2611
2022 Q2	$145K	Buy	4,030 +1,920	+91%	+$86.7K	﹤0.01%	2575
2022 Q1	$131K	Sell	2,110 -740	-26%	-$43.8K	﹤0.01%	2209
2021 Q4	$201K	Buy	2,850 +1,430	+101%	+$102K	﹤0.01%	2090
2021 Q3	$99K	Buy	+1,420	New	+$113K	﹤0.01%	2104

Other funds holding HBIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return

AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

State of Wisconsin Investment Board's HBIO Position: Q3 2024 in Review

State of Wisconsin Investment Board sold out of Harvard Bioscience (HBIO) in Q3 2024, closing a stake of 2,020 shares — an estimated $57.6K sold.

State of Wisconsin Investment Board first reported a position in HBIO in Q3 2021 and held it in 7 quarters. The position peaked at $201K in Q4 2021. 95 funds tracked by Wall St. Rank hold HBIO as of Q3 2024.

State of Wisconsin Investment Board reported no remaining Harvard Bioscience position as of Q3 2024 after selling out during the quarter.
State of Wisconsin Investment Board sold 2,020 Harvard Bioscience shares in Q3 2024, an estimated $57.6K.
State of Wisconsin Investment Board first reported a position in Harvard Bioscience in Q3 2021 and held it in 7 quarters.
State of Wisconsin Investment Board's Harvard Bioscience position peaked at $201K in Q4 2021.
95 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2024.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2024, filed 14 Nov 2024.